Scale -

  • Revenue is 53.33 Rs Cr; Continuous Growth over 3 years
  • Quarterly Revenue is 14.28 Rs Cr; Continuous Growth over 3 Quarters; in Bottom Quartile
  • PBT is 0.34 Rs Cr; Annual Decline is -45 %
  • PAT is -1.71 Rs Cr; Annual Decline is -123 %; in Bottom Quartile

Profitability -

  • PBDIT Margin is 41.04 %; in Top Quartile; Annual Decline is -24 %
  • Quarterly Ebitda Margin is 35 %; in Top Quartile; Continuous Decline over 3 Quarters
  • PAT Margin is -3.2 %; Annual Decline is -121 %; in Bottom Quartile
  • Quarterly Profit margin is 1 %; in Bottom Quartile

Return -

  • ROCE is 7.59 %; Annual Decline is -46 %
  • ROA is -0.95 %; Annual Decline is -119 %; in Bottom Quartile
  • ROE is -1.83 %; Annual Decline is -120 %; in Bottom Quartile

Efficiency -

  • Operating cash flow is 34.93 Rs Cr; Annual Growth is 195 %; 5 Year CAGR is 26 %
  • Inventory Turnover Ratio is 6.69; Continuous Growth over 3 years
  • Current Ratio is 0.94; Annual Decline is -38 %; in Bottom Quartile
  • Quick Ratio is 0.67; Annual Decline is -46 %; in Bottom Quartile

Solvancy -

  • Long term Debt is 46.61 Rs Cr; Annual Growth is 33 %; in Top Quartile
  • Debt/Equity is 0.72; in Top Quartile

Quality -

  • Operating cashflow/ebitda is 160 %; Annual Growth is 241 %; in Top Quartile; 5 Year CAGR is 16 %
  • Current Tax/PAT is -381 %; Annual Decline is -1435 %; Continuous Decline over 3 years; in Bottom Quartile
  • Change in Inventories/Total Expenses is -1 %; Annual Decline is -132 %; in Bottom Quartile
  • Other Expenses/Total Expenses is 15 %; Continuous Decline over 3 years; in Bottom Quartile
  • Exceptional Items/PBT is -12 %; in Bottom Quartile
  • Operating cashflow/PAT is -20.43 %; Annual Decline is -1357 %; Continuous Decline over 3 years; in Bottom Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector
Major Subsidiaries/Associates
Key Clients

Products

Products
Product details

Operations

Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
CRISPR Breakthrough: First In Vivo Prime Editing Treatment Tested in Humans
Read More
  • Past/current
Vivo Bio Tech Ltd. Estimates – NSE:VIVOBIOT
Read More
  • Past/current
Vivo Bio Tech Reports Fire Incident at Telangana Research Facility
Read More
  • Past/current
Vivo Bio Tech: ????????? ????????? ????????? ?? ???????! ??????? ???????? ?????
Read More
  • Past/current